LRIG3 and glioblastoma: Our previous studies have demonstrated that LRIG3 and sLRIG3 downregulate the MET/ Phosphatidylinositol 3-kinase/Akt signaling pathway in glioma tumor cells and inhibit GBM proliferation and invasion [17].